Most recent
Most popular
Popular science
Science
Populärvetenskap
Vetenskap
Lärardagar
Nobel

Search results: Research policy

No videos found

How do we assess scientific quality?
Opening address by Hans Ellegren, Vice President of the Royal Swedish Academy of Sciences and Maria Tenje, Chair of the Young Academy of Sweden. From: How do we assess scientific quality? 2019-05-23.
How ERC changed the European research landscape
Jean-Pierre Bourguignon, President of the European Research Council, EU. Introduction by symposium moderator Eva Krutmeijer. From: How do we assess scientific quality? 2019-05-23.
The Knut and Alice Wallenberg Foundation’s strategy for excellence in research
Göran Sandberg, Executive Director of the Knut and Alice Wallenberg Foundation, Sweden. Introduction by moderator Eva Krutmeijer. From: How do we assess scientific quality? 2019-05-23.
How scientific quality was improved in Denmark
Liselotte Højgaard, member of the Board of Directors of the Novo Nordisk Foundation, Denmark. Introduction by moderator Eva Krutmeijer. From: How do we assess scientific quality? 2019-05-23.
Can we learn something from Denmark? How should faculty appropriations/external funding be balanced?
Conversations with Gunnar Öquist, former Secretary General, the Royal Swedish Academy of Sciences; Mia Phillipson, Uppsala University; Sven Stafström, Director General of the Swedish Research Council; Astrid Söderbergh Widding, President of Stockholm University. From: How do we assess scientific quality? 2019-05-23.
Quality, Originality, and Risk-taking. Experiences and Experiments of the Volkswagen Foundation
Wilhelm Krull, Secretary General of the Volkswagen Foundation, Germany. Introduction by moderator Eva Krutmeijer. From: How do we assess scientific quality? 2019-05-23.
What is meant by strategic research? How to ascertain high quality?
Conversation with Lars Hultman, Chief Executive Officer of the Swedish Foundation for Strategic Research and Klas Kärre, Karolinska Institutet, Sweden. From: How do we assess scientific quality? 2019-05-23.
Let us experiment with how to identify and support innovative research
Thomas Sinkjæer, the Lundbeck Foundation, Denmark. Introduction by moderator Eva Krutmeijer. From: How do we assess scientific quality? 2019-05-23.
What is most important – past performance of the researcher or excellent ideas? How do we best promote young scientists?
Conversations with Joseph Samec, Stockholm University, Sweden; Jonas Olofsson, Stockholm University, Sweden; Mia Phillipson, Uppsala University, Sweden. From: How do we assess scientific quality? 2019-05-23.
Panel discussion with funding agencies – How do we assess scientific quality?
Lars Hultman, Chief Executive Officer of the Swedish Foundation for Strategic Research; Göran Sandberg, Executive Director of the Knut and Alice Wallenberg Foundation, Sweden; Sven Stafström, Director General of the Swedish Research Council; Britt-Marie Sjöberg, Chief Executive Officer of the Wenner-Gren Foundations, Sweden. – How to create funding programmes that promote breakthrough science? – How do funders identify applications and/or individuals that will generate breakthrough science? From: How do we assess scientific quality? 2019-05-23.
Panel discussion with scientists – How do we assess scientific quality?
Helena Edlund, Umeå University, Sweden; Arne Jarrick, Stockholm University, Sweden; Jonas Olofsson, Stockholm University, Sweden; Maria Tenje, Chair of the Young Academy of Sweden. – How to create funding programmes that promote breakthrough science? – How do funders identify applications and/or individuals that will generate breakthrough science? Closing words by Christina Moberg, Former President, the Royal Swedish Academy of Sciences. From: How do we assess scientific quality? 2019-05-23.
British Medical Research Council's support program for industry related Ph.D. training
Peter Dukes, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03
IMI initiated Ph.D. programs
Mike Hardman, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03
Experience from collaboration with drug companies and small/medium size enterprises
Karl Tryggvason, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03
Experience from collaboration with drug companies and small/medium size enterprises
Sven Enerbäck, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03
The innovative medicines initiative - first acheivements and future plans
Michel Goldman, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03
Introduction
Olle Lindvall, Anita Aperia, How increased interaction between basic biomedical research and pharmaceutical industry will make Sweden more competitive, 2011-02-03